Xenetic Biosciences Inc (XBIO)
4.05
-0.09
(-2.17%)
USD |
NASDAQ |
Apr 19, 16:00
4.05
0.00 (0.00%)
After-Hours: 20:00
Xenetic Biosciences Free Cash Flow (Quarterly): -0.793M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.793M |
| September 30, 2023 | -0.9496M |
| June 30, 2023 | -1.269M |
| March 31, 2023 | -1.102M |
| December 31, 2022 | -0.7509M |
| September 30, 2022 | -1.079M |
| June 30, 2022 | -1.229M |
| March 31, 2022 | -2.088M |
| December 31, 2021 | -1.459M |
| September 30, 2021 | -1.033M |
| June 30, 2021 | -0.7268M |
| March 31, 2021 | -1.519M |
| December 31, 2020 | -0.9537M |
| September 30, 2020 | -1.012M |
| June 30, 2020 | -1.301M |
| March 31, 2020 | -1.001M |
| December 31, 2019 | -1.678M |
| September 30, 2019 | -2.416M |
| June 30, 2019 | -1.051M |
| March 31, 2019 | -1.254M |
| December 31, 2018 | -1.041M |
| September 30, 2018 | -1.668M |
| June 30, 2018 | -2.088M |
| March 31, 2018 | -1.667M |
| December 31, 2017 | 4.838M |
| Date | Value |
|---|---|
| September 30, 2017 | -1.637M |
| June 30, 2017 | -1.992M |
| March 31, 2017 | 0.2754M |
| December 31, 2016 | -4.626M |
| September 30, 2016 | -1.029M |
| June 30, 2016 | -1.359M |
| March 31, 2016 | -1.790M |
| December 31, 2015 | -1.116M |
| September 30, 2015 | -1.955M |
| June 30, 2015 | -0.1952M |
| March 31, 2015 | -2.036M |
| December 31, 2014 | -2.676M |
| September 30, 2014 | -2.689M |
| June 30, 2014 | -3.234M |
| March 31, 2014 | -4.141M |
| November 30, 2013 | -0.1731M |
| August 31, 2013 | 0.2504M |
| May 31, 2013 | 0.0172M |
| February 28, 2013 | 0.013M |
| November 30, 2012 | 0.00 |
| August 31, 2012 | -0.0011M |
| May 31, 2012 | -0.0133M |
| February 29, 2012 | 0.0032M |
| November 30, 2011 | -0.0018M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-2.416M
Minimum
Sep 2019
-0.7268M
Maximum
Jun 2021
-1.232M
Average
-1.079M
Median
Sep 2022
Free Cash Flow (Quarterly) Benchmarks
| Perspective Therapeutics Inc | -9.097M |
| Electromed Inc | 3.384M |
| Xtant Medical Holdings Inc | -1.278M |
| Asensus Surgical Inc | -13.45M |
| Myomo Inc | -2.387M |